FDA inspection
Hemarus LLC: FDA inspection ending Apr 30, 2024
FDA inspection 1234618 · Official Action Indicated (OAI) · Lauderhill, FL
Key facts
| Inspection ID | 1234618 |
|---|---|
| Firm | Hemarus LLC |
| FEI number | 3019769008 |
| Address | 1295 Nw 40th Ave Ste 201 |
| City | Lauderhill |
| State | FL |
| ZIP | 33313 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Apr 30, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
| Warning letter | 688656 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data